The DOI matches its Crossref record; 1,258 of the 1,268 references it cites were found in a registry or an index.
Pharmacology and behavioral pharmacology of the mesocortical dopamine system
Abstract
The prefrontal cortex (PFC) has long been known to be involved in the mediation of complex behavioral responses. Considerable research efforts are directed towards refining the knowledge about the function of this brain area and the role it plays in cognitive performance and behavioral output. In the first part, this review provides, from a pharmacological perspective, an overview of anatomical, electrophysiological and neurochemical aspects of the function of the PFC, with an emphasis on the mesocortical dopamine system. Anatomy of the mesocortical system, basic physiological and pharmacological properties of neurotransmission within the PFC, and interactions between dopamine and glutamate as well as other transmitters within the mesocorticolimbic circuit are included. The coverage of these data is largely restricted to what is relevant for the second part of the review which focuses on behavioral studies that have examined the role of the PFC in a variety of phenomena, behaviors and paradigms. These include reward and addiction, locomotor activity and sensitization, learning, cognition, and schizophrenia. Although the focus of this review is on the mesocortical dopamine system, given the intricate interactions of dopamine with other transmitter systems within the PFC and the importance of the PFC as a source of glutamate in subcortical areas, these aspects are also covered in some detail where appropriate. Naturally, a topic as complex as this cannot be covered comprehensively in its entirety. Therefore this review is largely limited to data derived from studies using rats, and it is also specifically restricted to data concerning the medial PFC (mPFC). Since in several fields of research the findings concerning the function or role of the mPFC are relatively inconsistent, the question is addressed whether these inconsistencies might, at least in part, be related to the anatomical and functional heterogeneity of this brain area.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In contrast, in frontal cortex, because of low concentrations of the dopamine reuptake molecule DAT, it takes much longer to clear dopamine from synapses (for reviews, see, e.g., [72–74]).”
From Cortical and basal ganglia contributions to habit learning and automaticity (2010) · cites this paper as [72]
Citations
Cites
Plum, F. (1960) · Archives of Neurology · doi:10.1001/archneur.1960.03840090124020 · Cited by 10,388
A neural substrate of prediction and reward
Schultz, W., Dayan, P., & Montague, P. R. (1997) · Science · doi:10.1126/science.275.5306.1593 · Cited by 9,388
Parallel organization of functionally segregated circuits linking basal ganglia and cortex
Alexander, G. E., DeLong, M. R., & Strick, P. L. (1986) · Annual Review of Neuroscience · doi:10.1146/annurev.ne.09.030186.002041 · Cited by 8,527
Handbook of Chemical Neuroanatomy
Stern, C. D. (1986) · Neurochemistry International · doi:10.1016/0197-0186(86)90021-5 · Cited by 4,160
Implications of Normal Brain Development for the Pathogenesis of Schizophrenia
Weinberger, D. R. (1987) · Archives of General Psychiatry · doi:10.1001/archpsyc.1987.01800190080012 · Cited by 3,724
Morris, R. G. M., Anderson, E., Lynch, G. S., & Baudry, M. (1986) · Nature · doi:10.1038/319774a0 · Cited by 3,640
Krystal, J. H. (1994) · Archives of General Psychiatry · doi:10.1001/archpsyc.1994.03950030035004 · Cited by 3,330
Psychopharmacology: The Fourth Generation of Progress
Bloom, F. E., & Kupfer, D. J. (1995) · Medical Entomology and Zoology · Cited by 2,985
Recent advances in the phencyclidine model of schizophrenia
(1991) · American Journal of Psychiatry · doi:10.1176/ajp.148.10.1301 · Cited by 2,904
The somatic marker hypothesis and the possible functions of the prefrontal cortex
Damasio, A. R. (1996) · Philosophical Transactions of the Royal Society of London. Series B: Biological Sciences · doi:10.1098/rstb.1996.0125 · Cited by 2,847
Research works printed but not linked: 50
- Arvanitogiannis, 1997, Fos expression following self-stimulation of the medial prefrontal cortex, Soc. Neurosci. Abstr., 23, 2384
- Bauco, 1994, Extracellular nucleus accumbens dopamine and metabolite levels during earned and unearned lateral hypothalamic brain stimulation, Soc. Neurosci. Abstr., 20, 823
- Carr, G.D., Fibiger, H.C., Phillips, A.G., 1989. Conditioned place preference as a measure of drug reward. In: J.M. Liebman, S.J. Cooper (Eds.), The Neuropharmacological Basis of Reward. Clarendon Press, Oxford, pp. 264–319.
- Carter, 1980, Glutamatergic pathways from the medial pre-frontal cortex to the anterior striatum, nucleus accumbens and substantia nigra, Br. J. Pharmacol., 70, 50
- Carter, 1978, Studies on the roles of catecholamines in the frontal cortex, Br. J. Pharmacol., 62, 402P
- Childress, 1996, Brain correlates of cue-induced and opiate craving, Soc. Neurosci. Abstr., 22, 365.5
- Conover, 1992, Coactivation of the lateral hypothalamus and ventral tegmental area yields greater reward summation than coactivation of the lateral hypothalamus and medial pre-frontal cortex, Soc. Neurosci. Abstr., 18, 709
- Di Chiara, 1992, Heterologous monoamine uptake: lack of transmitter specificity of neuron-specific carriers, Neurochem. Int., 20, 231S
- Ditzler, 1991, Efficacy and tolerability of memantine in patients with dementia syndrome, Arzneimittelforschung/Drug Res., 8, 773
- Douglin, 1979, Gradual increases in self-stimulation response rates: effect of electrode loci, Physiol. Behav., 7, 135
- Feenstra, 1993, In vivo dopamine release in the rat prefrontal cortex is increased by stimulation of mediodorsal thalamic nucleus, Soc. Neurosci. Abstr., 19, 1382
- Feenstra, 1995, Local application of a competitive NMDA antagonist in the medial prefrontal cortex increases in vivo DA but not NA release, Br. J. Pharmacol., 114, 328P
- Forno, L.S., 1990. Pathology of Parkinson's disease: the importance of the substantia nigra and Lewy bodies. In: Stern, G. (Ed.), Parkinson's Disease. Chapman and Hall, London, pp. 185–238.
- Fuster, J., 1980. The prefrontal cortex. Raven Press, New York.
- Gabbott, 1996, Local circuit neurons in the medial prefrontal cortex (areas 24a,b,c, 25 and 32) in the monkey: II. Quantitative arial and laminar distributions, J. Comp. Neurol., 364, 609, 10.1002/(SICI)1096-9861(19960122)364:4<609::AID-CNE2>3.0.CO;2-7 · DOI
- Gillham, 1990, GABA neurons in the ventral tegmental area project to the medial prefrontal cortex: a non-dopaminergic mesocortical system, Soc. Neurosci. Abstr., 16, 105
- Grace, 1984, Electrophysiology and morphology of four classes of prefrontal neocortical neurons studied in vitro, Soc. Neurosci. Abstr., 10, 739
- Gresch, 1995, Stress-induced sensitization of dopamine and norepinephrine efflux in medial prefrontal cortex of the rat, J. Neurochem., 65, 575, 10.1046/j.1471-4159.1995.65010111.x · DOI
- Hemby, 1990, Neuropharmacological assessment of cocaine-induced conditioned place preference using intra-cranial microinjections, Soc. Neurosci. Abstr., 16, 243.6
- Hoffmann, 1986, Multiple effects of neuronal uptake inhibitors on transmitter release, J. Pharmacol. Exp. Ther., 238, 437
- Koob, G.F., Goeders, N.E., 1989. Neuroanatomical substrates of drug self-administration. In: Liebman, J.M., Cooper, S.J. (Eds.), The neuropharmacological basis of reward. Clarendon Press, Oxford, pp. 214–236.
- Kuczenski, R., Segal, D.S., 1994. Neurochemistry of amphetamine. In: Cho, A., Segal, D.S. (Eds.), Amphetamine and its analogs. Academic Press, San Diego, pp. 81–113.
- Kurata, 1993, Differential effects of tight and loose 2-h restraint stress on extracellular concentrations of dopamine in nucleus accumbens and anteromedial frontal cortex, Jpn. J. Psychiatry Neurol., 47, 57
- Lindvall, O., Björklund, A., 1984. In: Descarries, L., Reader, T.R., Jasper, H.H. (Eds.), General organization of cortical monoamine systems. Liss, New York.
- Lu, 1997, Expression of D1 receptor mRNA in projections from the forebrain to the ventral tegmental area, Synapse, 25, 205, 10.1002/(SICI)1098-2396(199702)25:2<205::AID-SYN11>3.0.CO;2-X · DOI
- Moore, 1996, Interactions between amygdala and prefrontal cortical afferents to the nucleus accumbens and their modulation by dopamine receptor activation, Soc. Neurosci. Abstr., 22, 1088
- Moore, R.Y., Card, J.P., 1984. Noradrenaline-containing neuron systems. In: Björklund, A., Hökfelt, T. (Eds.), Handbook of Chemical Neuroanatomy, vol. 2. Elsevier, Amsterdam, pp. 123–156.
- Muly, 1997, D1 dopamine receptors are present in parvalbumine-positive interneurons in macaque prefrontal cortex, Soc. Neurosci. Abstr., 23, 1772
- Nishijima, 1996, Differential effects of phencyclidine and methamphetamine on dopamine metabolism in rat frontal cortex and striatum as revealed by in vivo dialysis, Synapse, 22, 304, 10.1002/(SICI)1098-2396(199604)22:4<304::AID-SYN2>3.0.CO;2-F · DOI
- Nonneman, 1974, Comparisons of behavioral effects of hippocampal and prefrontal cortex lesions in the rat, J. Comp. Physiol. Psychol., 87, 249, 10.1037/h0036864 · DOI
- Palkovits, M., 1979. Dopamine levels of individual brain regions: biochemical aspects of DA distribution in the central nervous system. Academic Press, London, pp. 343–356.
- Phillips, A.G., Fibiger, H.C., 1989. Neuroanatomical bases of intracranial self-stimulation: untangling the Gordian knot. In: Liebman, J.M., Cooper, S.J. (Eds.), The neuropharmacological basis of reward. Clarendon Press, Oxford, pp. 66–105.
- Pickel, V.M., Sesack, S.M., 1995. Electron microscopy of central dopamine systems. In: Bloom, F.E., Kupfer, D.J. (Eds.), Psychopharmacology: The fourth generation of progress. Raven Press, New York, pp. 257–268.
- Seamans, 1995, Selective impairment on a delayed radial arm task following local administration of a D1, but not a D2, antagonist into the prefrontal cortex, Soc. Neurosci. Abstr., 21, 1942
- Shibata, 1990, Effect of dopamine agonists on locomotor activity of anteromedial frontal cortex lesioned rats, Jpn. J. Psychiatry Neurol., 44, 789
- Shippenberg, 1993, Examination of the neurochemical substrates mediating the motivational effects of opioids: role of the mesolimbic dopamine system and D1 versus D2 dopamine receptors, J. Pharmacol. Exp. Ther., 265, 53
- Simon, 1981, Dopaminergic A10 neurons and the frontal system, J. Physiol., 77, 81
- Smiley, 1996, Serotonergic axons in monkey prefrontal cerebral cortex synapse predominantly on interneurons as demonstrated by serial section electron microscopy, J. Comp. Neurol., 367, 431, 10.1002/(SICI)1096-9861(19960408)367:3<431::AID-CNE8>3.0.CO;2-6 · DOI
- Smith, 1998, Microcircuitry of the direct and indirect pathways of the basal ganglia, Neuroscience, 86, 353
- Stellar, J.R., Rice, M.B., 1989. Pharmacological basis of intracranial self-stimulation reward. In: Liebman, J.M., Cooper, S.J. (Eds.), The neuropharmacological basis of reward. Clarendon Press, Oxford, pp. 14–65.
- Taylor, 1978, Comparison of monoamine uptake by cocaine, methylphenidate and amphetamine, Res. Commun. Pathol. Pharmacol., 21, 67
- Thierry, A.M., Tassin, J.P., Blanc, G., Glowinski, J., 1976b. Topographical and pharmacological study of the mesocortical dopaminergic systems. In: Wauqnier, A., Rolls, E.T. (Eds.), Brain Stimulation Reward. North-Holland, Amsterdam, pp. 290–293.
- Tzschentke, 1997, Electrical stimulation of the medial prefrontal cortex elicits release of dopamine and glutamate in nucleus accumbens and ventral tegmental area in rats: effects of different frequencies and currents, Soc. Neurosci. Abstr., 23, 1753
- Tzschentke, T.M., Schmidt, W.J., 1998b. Functional heterogeneity of the medial prefrontal cortex and its relevance for drug reward. On-line Proceedings of the Fifth Internet World Congress on Biomedical Sciences (INABIS)’ 98 at McMaster University, Canada (available from URL: http://www.mcmaster.ca/inabis98/).
- Uylings, H.B.M., van Eden, C.G., De Bruin, J.P.C., Corner, M.A., Feenstra, M.G.P. (Eds.), 1990. The prefrontal cortex—its structure, function and pathology. Progress in Brain Research, vol. 85. Elsevier, Amsterdam.
- van Eden, 1997, Efferents from the rat medial prefrontal cortex can influence dopaminergic cells in the ventral tegmental area, which project to the nucleus accumbens, Soc. Neurosci. Abstr., 23, 1213
- Weiner, 1990, Disruption of latent inhibition by a low dose of amphetamine is antagonised by haloperidol and apomorphine, J. Psychopharmacol., 4, 255
- White, F.J., Wachtel, S.R., Johansen, P.A., Einhorn, L.C., 1987. Electrophysiological studies of the rat mesoaccumbens dopamine systems: focus on dopamine receptor subtypes, interactions, and the effect of cocaine. In: Chiodo, L.A., Freeman, F.A. (Eds.), Neurophysiology of dopaminergic systems: current status and clinical perspectives. Lakeshore, Detroit, pp. 317–365.
- White, F.J., Hu, X.T., Henry, D.J., Zhang, X.F., 1995a. Neurophysiological alterations in the mesocorticolimbic dopamine system with repeated cocaine administration. In: Hammer Jr, R.P. (Ed.), The Neurobiology of Cocaine: Cellular and Molecular Mechanisms. CRC Press, Boca Raton, FL, pp. 99–119.
- Yang, 1996, Focal dendritic D1 receptor stimulation differentially modulates layers I-II and V-VI glutamate inputs to deep layer prefrontal cortical pyramidal neurons in vitro, Soc. Neurosci. Abstr., 22, 1770
Cited by
Sorted by citations
Items 101–200 of 481
Leung, S., Croft, R. J., Baldeweg, T., & Nathan, P. J. (2007) · Psychopharmacology · doi:10.1007/s00213-007-0865-1 · Cited by 81
Dysregulation of the Mesolimbic Dopamine System and Reward in MCH−/− Mice
Pissios, P., Frank, L., Kennedy, A. R., Porter, D. R., Marino, F. E., Liu, F., Pothos, E. N., & Maratos–Flier, E. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2007.12.011 · Cited by 79
Forced Abstinence Model of Relapse to Study Pharmacological Treatments of Substance Use Disorder
Reichel, C. M., & Bevins, R. A. (2009) · Current Drug Abuse Reviews · doi:10.2174/1874473710902020184 · Cited by 79
Flores, C., Manitt, C., Rodaros, D., Thompson, K. M., Rajabi, H., Luk, K. C., Tritsch, N. X., Sadikot, A. F., Stewart, J., & Kennedy, T. E. (2004) · Molecular Psychiatry · doi:10.1038/sj.mp.4001607 · Cited by 79
Balfour, M. E., Brown, J. L., Yu, L., & Coolen, L. M. (2006) · Neuroscience · doi:10.1016/j.neuroscience.2005.11.013 · Cited by 78
Young, C. E., & Yang, C. R. (2004) · Journal of Neuroscience · doi:10.1523/jneurosci.1650-03.2004 · Cited by 78
Tanaka, S. (2005) · Neuroscience · doi:10.1016/j.neuroscience.2005.08.070 · Cited by 79
Eytan, D., Minerbi, A., Ziv, N. E., & Marom, S. (2004) · Journal of Neurophysiology · doi:10.1152/jn.00202.2004 · Cited by 72
Gender-specific effects of social housing on chronic stress-induced limbic FOS expression
Westenbroek, C., den Boer, J. A., & Horst, G. J. T. (2003) · Neuroscience · doi:10.1016/s0306-4522(03)00367-1 · Cited by 73
Yap, J. J., Covington, H. E., Gale, M. C., Datta, R., & Miczek, K. A. (2004) · Psychopharmacology · doi:10.1007/s00213-004-2023-3 · Cited by 71
Hirvonen, J., Karlsson, H., Kajander, J., Markkula, J., Rasi-Hakala, H., Någren, K., Salminen, J. K., & Hietala, J. A. (2008) · Psychopharmacology · doi:10.1007/s00213-008-1088-9 · Cited by 70
Minocycline attenuates subjective rewarding effects of dextroamphetamine in humans
Sofuoglu, M., Mooney, M. E., Kosten, T. R., Waters, A. J., & Hashimoto, K. (2010) · Psychopharmacology · doi:10.1007/s00213-010-2014-5 · Cited by 70
Lin, S., Pan, W. H. T., & Yeh, P.-H. (2006) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2006.10.001 · Cited by 69
Brain neurotensin, psychostimulants, and stress – emphasis on neuroanatomical substrates
Geisler, S., Bérod, A., Zahm, D. S., & Rostène, W. H. (2006) · Peptides · doi:10.1016/j.peptides.2006.03.037 · Cited by 66
Huang, C., Yang, P.-C., Lin, H.-J., & Hsu, K. (2007) · Journal of Neuroscience · doi:10.1523/jneurosci.4247-06.2007 · Cited by 68
Cetin, T., Freudenberg, F., Füchtemeier, M., & Koch, M. (2004) · Neuroscience Letters · doi:10.1016/j.neulet.2004.08.002 · Cited by 68
Cannabinoid agonist-induced sensitisation to morphine place preference in mice
Manzanedo, C., Aguilar, M. A., Rodríguez‐Arias, M., Navarro, M. A., & Miñarro, J. (2004) · Neuroreport · doi:10.1097/01.wnr.0000126217.87116.8c · Cited by 67
Komada, M., Hara, N., Kawachi, S., Kawachi, K., Kagawa, N., Nagao, T., & Ikeda, Y. (2017) · Scientific Reports · doi:10.1038/s41598-017-04289-1 · Cited by 70
Genetic Determinants of Addiction to Opioids and Cocaine
Saxon, A. J., Oreskovich, M. R., & Brkanac, Z. (2005) · Harvard Review of Psychiatry · doi:10.1080/10673220500243364 · Cited by 66
Automaticity and multiple memory systems
Ashby, F. G., & Crossley, M. J. (2012) · Wiley Interdisciplinary Reviews Cognitive Science · doi:10.1002/wcs.1172 · Cited by 64
Neuropeptidergic regulation of pair-bonding and stress buffering: Lessons from voles
Gobrogge, K. L., & Wang, Z. (2015) · Hormones and Behavior · doi:10.1016/j.yhbeh.2015.08.010 · Cited by 64
Shoblock, J. R., Maisonneuve, I. M., & Glick, S. D. (2003) · Psychopharmacology · doi:10.1007/s00213-003-1522-y · Cited by 64
Guo, Y., Wang, H., Xiang, X., & Zhao, Y. (2009) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2009.02.005 · Cited by 62
Differential cannabinoid-induced electrophysiological effects in rat ventral tegmentum
Cheer, J. F., Kendall, D. A., Mason, R., & Marsden, C. A. (2003) · Neuropharmacology · doi:10.1016/s0028-3908(03)00029-7 · Cited by 62
Zhang (2010) · Frontiers in Neuroanatomy · doi:10.3389/fnana.2010.00021 · Cited by 61
Arco, A. D., Segovia, G., & Mora, F. (2008) · Psychopharmacology · doi:10.1007/s00213-008-1288-3 · Cited by 60
Phasic Dopamine Neuron Activity Elicits Unique Mesofrontal Plasticity in Adolescence
Mastwal, S. S., Ye, Y., Ren, M., Jimenez, D. V., Martinowich, K., Gerfen, C. R., & Wang, K. H. (2014) · Journal of Neuroscience · doi:10.1523/jneurosci.1114-14.2014 · Cited by 61
Fooladsaz, K., Negahdary, M., Rahimi, G., Habibi-Tamijani, A., Parsania, S., Dastjerdi, H. A., Sayad, A., Jamaleddini, A., Salahi, F., & Asadi, A. (2012) · International Journal of Electrochemical Science · doi:10.1016/s1452-3981(23)16246-8 · Cited by 59
A tutorial on computational cognitive neuroscience: Modeling the neurodynamics of cognition
Ashby, F. G., & Hélie, S. (2011) · Journal of Mathematical Psychology · doi:10.1016/j.jmp.2011.04.003 · Cited by 59
Differential dopaminergic modulation of executive control in healthy subjects
Roesch-Ely, D., Scheffel, H., Weiland, S., Schwaninger, M., Hundemer, H.-P., Kolter, T., & Weisbrod, M. (2005) · Psychopharmacology · doi:10.1007/s00213-004-2027-z · Cited by 56
Social defeat stress, sensitization, and intravenous cocaine self-administration in mice
Yap, J. J., & Miczek, K. A. (2007) · Psychopharmacology · doi:10.1007/s00213-007-0712-4 · Cited by 56
Infralimbic D2 receptor influences on anxiety-like behavior and active memory/attention in CD-1 mice
Wall, P. M., Blanchard, R. J., Yang, M., & Blanchard, D. C. (2003) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/s0278-5846(02)00356-1 · Cited by 56
Du, Z. J., Bi, G., & Cui, X. T. (2017) · Advanced Functional Materials · doi:10.1002/adfm.201703988 · Cited by 55
del Arco, A., & Mora, F. (2004) · Journal of Neural Transmission · doi:10.1007/s00702-004-0172-5 · Cited by 54
Richetto, J., Polesel, M., & Weber‐Stadlbauer, U. (2018) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2018.05.011 · Cited by 60
Genetic NMDA Receptor Deficiency Disrupts Acute and Chronic Effects of Cocaine but not Amphetamine
Ramsey, A. J., Laakso, A., Cyr, M., Sotnikova, T. D., Salahpour, A., Medvedev, I. O., Dykstra, L., Gainetdinov, R. R., & Caron, M. G. (2008) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301663 · Cited by 53
Dazzi, L., Serra, M., Seu, E., Cherchi, G., Pisu, M. G., Purdy, R. H., & Biggio, G. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.01218.x · Cited by 52
Weber‐Stadlbauer, U., Woods, S. C., Langhans, W., & Meyer, U. (2014) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2014.12.003 · Cited by 56
Komada, M., Itoh, S., Kawachi, K., Kagawa, N., Ikeda, Y., & Nagao, T. (2014) · Toxicology · doi:10.1016/j.tox.2014.06.009 · Cited by 53
Quantifying the psychomotor activating effects of cocaine in the rat
Flagel, S. B., & Robinson, T. E. (2007) · Behavioural Pharmacology · doi:10.1097/fbp.0b013e3281f522a4 · Cited by 48
Yilmazer‐Hanke, D. (2008) · Behavioural Pharmacology · doi:10.1097/fbp.0b013e32830dc0de · Cited by 52
Psychopathology and Individual Differences in Latent Inhibition: Schizophrenia and Schizotypality
Lubow, R. E., & Kaplan, O. (2010) · Plenum series on human exceptionality · doi:10.1007/978-1-4419-1210-7_11 · Cited by 51
Dopaminergic Modulation of Appetitive and Aversive Predictive Learning
Iordanova, M. D. (2009) · Reviews in the Neurosciences · doi:10.1515/revneuro.2009.20.5-6.383 · Cited by 50
Hirvonen, J., Hietala, J. A., Kajander, J., Markkula, J., Rasi-Hakala, H., Salminen, J. K., Någren, K., Aalto, S., & Karlsson, H. (2010) · Journal of Psychopharmacology · doi:10.1177/0269881110376691 · Cited by 51
Leggio, G. M., Cathala, A., Moison, D., Cunningham, K. A., Piazza, P. V., & Spampinato, U. (2008) · Neuropharmacology · doi:10.1016/j.neuropharm.2008.10.005 · Cited by 50
Leggio, G. M., Cathala, A., Nény, M., Rougé‐Pont, F., Drago, F., Piazza, P. V., & Spampinato, U. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06356.x · Cited by 49
Sheng, H.-Y., Qu, C., Huo, F., Du, J., & Tang, J. (2008) · Experimental Neurology · doi:10.1016/j.expneurol.2008.09.018 · Cited by 48
Neurological soft signs in recent-onset schizophrenia: Focus on the cerebellum
Hirjak, D., Wolf, R. C., Kubera, K. M., Stieltjes, B., Maier-Hein, K. H., & Thomann, P. A. (2015) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2015.01.011 · Cited by 48
Marec, T. L., Cynthia Marie-claire, A., Noble, F., & Marie, N. (2011) · Psychopharmacology · doi:10.1007/s00213-011-2223-6 · Cited by 47
Zald, D. H., Woodward, N. D., Cowan, R. L., Riccardi, P., Ansari, M. S., Baldwin, R. M., Cowan, R. L., Smith, C. E., Hakyemez, H., Li, R., et al. (2010) · NeuroImage · doi:10.1016/j.neuroimage.2010.02.006 · Cited by 47
Markers of cognitive decline in PD: The case for heterogeneity
Monchi, O., Hanganu, A., & Bellec, P. (2016) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2016.01.002 · Cited by 47
Early life tactile stimulation changes adult rat responsiveness to amphetamine
Lovic, V., Fleming, A. S., & Fletcher, P. J. (2006) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2006.06.013 · Cited by 49
Fox, H. C., & Sinha, R. (2014) · Advances in pharmacology · doi:10.1016/b978-0-12-420118-7.00006-8 · Cited by 46
Szöke, A., Schürhoff, F., Méary, A., Mathieu, F., Chevalier, F., Trandafir, A., Alter, C., Roy, I., Bellivier, F., & Leboyer, M. (2006) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30352 · Cited by 46
Papadeas, S. T., Blake, B. L., Knapp, D. J., & Breese, G. R. (2004) · Journal of Neuroscience · doi:10.1523/jneurosci.0528-04.2004 · Cited by 45
Risperidone Pretreatment Prevents Elevated Locomotor Activity Following Neonatal Hippocampal Lesions
Richtand, N. M., Taylor, B., Welge, J. A., Ahlbrand, R., Ostrander, M. M., Burr, J., Hayes, S., Coolen, L. M., Pritchard, L. M., Logue, A., et al. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300791 · Cited by 45
Neurological Soft Signs and Brainstem Morphology in First-Episode Schizophrenia
Hirjak, D., Wolf, R. C., Stieltjes, B., Hauser, T., Seidl, U., Thiemann, U., Schröder, J., & Thomann, P. A. (2013) · Neuropsychobiology · doi:10.1159/000350999 · Cited by 44
Emack, J., & Matthews, S. G. (2011) · Hormones and Behavior · doi:10.1016/j.yhbeh.2011.08.008 · Cited by 45
Schlösser, R. G. M., Nenadić, I., Wagner, G., Zysset, S., Koch, K., & Sauer, H. (2009) · Synapse · doi:10.1002/syn.20621 · Cited by 45
Interaction of Satiety and Reward Response to Food Stimulation
James, G. A., Gold, M. S., & Liu, Y. (2004) · Journal of Addictive Diseases · doi:10.1300/j069v23n03_03 · Cited by 43
Biomarkers for Psychiatric Disorders
Turck, C. W. (2009) · Springer eBooks · doi:10.1007/978-0-387-79251-4 · Cited by 42
The effects of early‐life stress on dopamine system function in adolescent female rats
Majcher‐Maślanka, I., Solarz, A., Wędzony, K., & Chocyk, A. (2017) · International Journal of Developmental Neuroscience · doi:10.1016/j.ijdevneu.2017.01.001 · Cited by 44
Models of intervention and care for psychostimulant users
Baker, A., Lee, N., & Jenner, L. (2004) · Cited by 42
The Synaptic Pathology of Drug Addiction
van den Oever, M. C., Spijker, S., & Smit, A. B. (2012) · Advances in experimental medicine and biology · doi:10.1007/978-3-7091-0932-8_21 · Cited by 43
Devroye, C., Cathala, A., Piazza, P. V., & Spampinato, U. (2017) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2017.07.014 · Cited by 42
Competitive and cooperative interactions between medial temporal and striatal learning systems
Freedberg, M., Toader, A. C., Wassermann, E. M., & Voss, J. L. (2019) · Neuropsychologia · doi:10.1016/j.neuropsychologia.2019.107257 · Cited by 40
Molecular mechanisms of tolerance to and withdrawal of GABAA receptor modulators
Biggio, G., Dazzi, L., Biggio, F., Mancuso, L., Talani, G., Busonero, F., Mostallino, M. C., Sanna, E., & Follesa, P. (2003) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2003.08.002 · Cited by 41
Frankel, P. S., & Cunningham, K. A. (2002) · Brain Research · doi:10.1016/s0006-8993(02)03548-5 · Cited by 41
Xu, Q., Jia, Y.-B., Zhang, B., Zou, K., Tao, Y.-B., Wang, Y.-P., Qiang, B.-Q., Wu, G.-Y., Shen, Y., Ji, H.-K., et al. (2004) · Molecular Psychiatry · doi:10.1038/sj.mp.4001472 · Cited by 41
Bhardwaj, S. K., Beaudry, G., Quirion, R., Lévesque, D., & Srivastava, L. K. (2003) · Neuroscience · doi:10.1016/j.neuroscience.2003.08.016 · Cited by 41
Scornaiencki, R., Cantrup, R., Rushlow, W. J., & Rajakumar, N. (2009) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145709000121 · Cited by 40
Cortical control of VTA function and influence on nicotine reward
Wu, J., Gao, M., Shen, J.-X., Shi, W., Oster, A. M., & Gutkin, B. S. (2013) · Biochemical Pharmacology · doi:10.1016/j.bcp.2013.07.013 · Cited by 43
Mhyre, T. R., Chesler, E. J., Thiruchelvam, M. J., Lungu, C., Cory‐Slechta, D. A., Fry, J. D., & Richfield, E. K. (2004) · Genes Brain & Behavior · doi:10.1111/j.1601-183x.2004.00102.x · Cited by 40
A neural network model of Parkinson's disease bradykinesia
Vassilis Cutsuridis, A., & Perantonis, S. J. (2005) · Neural Networks · doi:10.1016/j.neunet.2005.08.016 · Cited by 40
Cocaine withdrawal and neuro-adaptations in ion channel function
Hu, X. (2007) · Molecular Neurobiology · doi:10.1007/bf02700626 · Cited by 39
Addiction to Food and Brain Reward Systems
Joranby, L., Frost-Pineda, K., & Gold, M. S. (2005) · Sexual Addiction & Compulsivity The Journal of Treatment and Prevention · doi:10.1080/10720160500203765 · Cited by 44
Zarrindast, M., Meshkani, J., Rezayof, A., Beigzadeh, R., & Rostami, P. (2010) · Neuroscience · doi:10.1016/j.neuroscience.2010.03.019 · Cited by 34
Smith, M. A., & Witte, M. A. (2012) · Experimental and Clinical Psychopharmacology · doi:10.1037/a0029724 · Cited by 38
Smith, M. A., Naples, J. G., Lyle, M. A., Iordanou, J. C., & Felder, J. N. (2009) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.108.150011 · Cited by 38
EVOLUTIONARY MISMATCH, NEURAL REWARD CIRCUITS, AND PATHOLOGICAL GAMBLING
Spinella, M. (2003) · International Journal of Neuroscience · doi:10.1080/00207450390162254 · Cited by 38
Neuroimaging studies of striatum in cognition part II: Parkinson's disease
Hanganu, A., Provost, J.-S., & Monchi, O. (2015) · Frontiers in Systems Neuroscience · doi:10.3389/fnsys.2015.00138 · Cited by 37
Braun, A. A., Amos‐Kroohs, R. M., Gutierrez, A., Lundgren, K. H., Seroogy, K. B., Vorhees, C. V., & Williams, M. T. (2016) · Neurotoxicity Research · doi:10.1007/s12640-016-9616-6 · Cited by 38
Peterson, J. D., Wolf, M. E., & White, F. J. (2006) · Journal of Neuroscience · doi:10.1523/jneurosci.2375-05.2006 · Cited by 37
Effect of Intrastriatal 6-OHDA Lesions on Extrastriatal Brain Structures in the Mouse
Becker, B., Demirbas, M., Johann, S., Zendedel, A., Beyer, C., Clusmann, H., Haas, S. J.-P., Wree, A., Tan, S. K. H., & Kipp, M. (2017) · Molecular Neurobiology · doi:10.1007/s12035-017-0637-9 · Cited by 40
Lessard, A., & Pickel, V. M. (2005) · Neuroscience · doi:10.1016/j.neuroscience.2005.07.025 · Cited by 35
Eells, J. B., Wilcots, J., Sisk, S., & Guo‐Ross, S. X. (2011) · Journal of Molecular Neuroscience · doi:10.1007/s12031-011-9642-z · Cited by 36
Arco, A. D., Mora, F., Mohammed, A. H., & Fuxé, K. (2006) · Journal of Neural Transmission · doi:10.1007/s00702-006-0533-3 · Cited by 36
Torrente, M., Colomina, M. T., & Domingo, J. L. (2005) · Toxicology · doi:10.1016/j.tox.2005.02.010 · Cited by 36
Computational Neuropsychiatry – Schizophrenia as a Cognitive Brain Network Disorder
Dauvermann, M. R., Whalley, H. C., Schmidt, A., Lee, G. L., Romaniuk, L., Roberts, N., Johnstone, E. C., Lawrie, S. M., & Moorhead, T. W. J. (2014) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2014.00030 · Cited by 36
Nigella sativa oil protects against emamectin benzoate‐Induced neurotoxicity in rats
Madkour, D. A., Ahmed, M. M., Orabi, S. H., Sayed, S. M. H., Korany, R. M. S., & Khalifa, H. K. (2021) · Environmental Toxicology · doi:10.1002/tox.23149 · Cited by 35
Li, Z., Bonhaus, D. W., Huang, M., Prus, A. J., Dai, J., & Meltzer, H. Y. (2007) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2007.06.025 · Cited by 35
Lack of behavioural effects after acute tyrosine depletion in healthy volunteers
Lythe, K. E., Anderson, I. M., Deakin, J. F. W., Elliott, R., & Strickland, P. (2005) · Journal of Psychopharmacology · doi:10.1177/0269881105048886 · Cited by 35
Mickiewicz, A. L., & Napier, T. C. (2010) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2010.07502.x · Cited by 34
Liu, X., Hou, Y., Yan, T., Guo, Y., Han, W., Guan, F., Chen, T., & Li, T. (2014) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.12276 · Cited by 34
Imeh‐Nathaniel, A., Rincon, N., Orfanakos, V. B., Brechtel, L. E., Wormack, L. N., Richardson, E., Huber, R., & Nathaniel, T. I. (2017) · Behavioural Brain Research · doi:10.1016/j.bbr.2017.05.069 · Cited by 34
Kao, J., Huang, E. Y., & Tao, P. (2011) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2011.04.019 · Cited by 33
Pharmacotherapy for Attention-Deficit/Hyperactivity Disorder: From Cells to Circuits
Minzenberg, M. (2012) · Neurotherapeutics · doi:10.1007/s13311-012-0128-7 · Cited by 36
From vice to virtue: Insights from sensitization in the nonhuman primate
Castner, S. A., & Williams, G. V. (2007) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2007.08.026 · Cited by 35
D2 dopamine receptor blockade prevents cognitive effects of Ang IV and des-Phe6 Ang IV
Braszko, J. J. (2006) · Physiology & Behavior · doi:10.1016/j.physbeh.2006.03.025 · Cited by 32
Neuropharmacology of Verbal Perseveration
McNamara, P., & Albert, M. L. (2004) · Seminars in Speech and Language · doi:10.1055/s-2004-837244 · Cited by 36
Metadata
- Authors
- Tzschentke, T. M.
- Affiliations
- Grünenthal Group (Germany) (DE)
- Corresponding author
- Tzschentke, T.M.
- ORCID
- Tzschentke, T.M.
- Venue
- Progress in Neurobiology
- Publisher
- Elsevier BV
- Published
- 2001-02
- Volume
- 63
- Issue
- 3
- Pages
- 241-320
- ISSN
- 0301-0082 (ISSN-L)
- OpenAlex
- W2111304405
- Semantic Scholar
- 314205aef63746557803f0214ed764321bbe28dc
- Cited by
- 481
- References
- 1,268
- Citations by year
- 2026: 1 · 2025: 4 · 2024: 9 · 2023: 19 · 2022: 7 · 2021: 6 · 2020: 8 · 2019: 13 · 2018: 6 · 2017: 17 · 2016: 14 · 2015: 24 · 2014: 21 · 2013: 11 · 2012: 24
- FWCI
- 2.59
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Progress in Neurobiology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Life Sciences › Neuroscience › Cognitive Neuroscience › Neural and Behavioral Psychology Studies
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Keywords
- mesocortical dopamine system, prefrontal cortex, medial prefrontal cortex, glutamate, dopamine-glutamate interaction, mesocorticolimbic circuit, reward, addiction, locomotor activity, sensitization, learning, cognition, schizophrenia
- MeSH terms
- Animals, Behavior, Animal, Dopamine, Humans, Synaptic Transmission, Neurons, Prefrontal Cortex, Ventral Tegmental Area
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review